Wednesday, 31 October 2018

FDA approves Novartis' copy of AbbVie bestseller Humira

The U.S. Food and Drug Administration (FDA) has approved Novartis AG's copy of Humira, the world's bestselling prescription medicine developed by U.S.-based AbbVie Inc, the agency's website showed on Wednesday.


from Reuters: Health News https://www.reuters.com/article/us-abbvie-novartis-fda/fda-approves-novartis-copy-of-abbvie-bestseller-humira-idUSKCN1N529J?feedType=RSS&feedName=healthNews

No comments:

Post a Comment